Literature DB >> 9225011

Influence of carcinogen binding by lactic acid-producing bacteria on tissue distribution and in vivo mutagenicity of dietary carcinogens.

F Bolognani1, C J Rumney, I R Rowland.   

Abstract

The aims of this investigation were to determine whether viable cultures of lactic acid-producing organisms (LAB) can bind dietary carcinogens and to assess the consequences of binding for the absorption from the gut, distribution in the body and in vivo genotoxicity of ingested carcinogens. The carcinogens used in this study were ones known to be present in the human diet, namely benzo[a]pyrene (B(a)P, aflatoxin B1 (AFB1) and the cooked food carcinogens 2-amino-3-methyl-3H-imidazo[4,5-f]quinoline (IQ), 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ), 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), 5-phenyl-2-amino-1-methylimidazo [4,5-f]pyridine (PhIP) and 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2). They represent a range of structural types so that the specificity of any binding effects could be addressed. Of the carcinogens tested, B(a)P and Trp-P-2 were bound most effectively by the two LAB strains Bifidobacterium longum and Lactobacillus acidophilus. AFB1 was poorly bound, while MeIQx, MeIQ, PhIP and IQ were bound to an intermediate degree. The extent of the binding of the heterocyclic amine carcinogens was dependent on the pH conditions during incubation and this effect was more apparent with B. longum than with L. acidophilus. Using the host-mediated assay (HMA), an in vivo bacterial mutation assay, it was demonstrated that the administration of bacterial cell suspensions of B. longum and L. acidophilus did not lead to a reduction in induced mutagenicity by MeIQ, MeIQx or Trp-P-2, detectable in the liver of treated mice compared with controls. The lack of a protective effect could not be attributed to a short period of contact between bacterial cells and mutagens, since similar results were obtained after preincubating bacteria and mutagens together at pH 5 for 50-60 min, to maximize the binding, before gavaging the mice. Lack of activity of B(a)P in the HMA prevented the determination of the effect of LAB on genotoxicity of the polycyclic aromatic hydrocarbon. However, it is clear from the radiolabel distribution study that the amount of the carcinogen entering the blood was not significantly reduced by B. longum administration. In addition, the amount of radiolabelled B(a)P that reached the target organs (liver, lungs and heart) was also not affected by the LAB administration. A similar lack of inhibitory effect of B. longum on blood concentration and accumulation in the liver of Trp-P-2 was apparent. The results of the present study suggest that although LAB may bind carcinogens in vitro, this does not lead to major changes in absorption and distribution of carcinogens in the body, or in their genotoxic activity in the liver.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9225011     DOI: 10.1016/s0278-6915(97)00029-x

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  13 in total

Review 1.  A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action.

Authors:  Esther Swee Lan Chong
Journal:  World J Microbiol Biotechnol       Date:  2013-09-26       Impact factor: 3.312

2.  Practical analysis of aflatoxin M1 reduction in pasteurized Milk using low dose gamma irradiation.

Authors:  Mehdi Hassanpour; Mohammad Reza Rezaie; Amin Baghizadeh
Journal:  J Environ Health Sci Eng       Date:  2019-11-13

Review 3.  Antimutagenic Activity as a Criterion of Potential Probiotic Properties.

Authors:  Evgeniya V Prazdnova; Maria S Mazanko; Vladimir A Chistyakov; Anna A Bogdanova; Aleksandr G Refeld; Evgeniya Y Kharchenko; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2022-01-14       Impact factor: 4.609

4.  Effects of dietary supplementation of bentonite and Saccharomyces cerevisiae cell wall on acute-phase protein and liver function in high-producing dairy cows during transition period.

Authors:  Seyed Amin Razavi; Mehrdad Pourjafar; Ali Hajimohammadi; Reza Valizadeh; Abbas Ali Naserian; Richard Laven; Kristina Ruth Mueller
Journal:  Trop Anim Health Prod       Date:  2019-01-30       Impact factor: 1.559

5.  Ability of probiotic Lactobacillus casei DN 114001 to bind or/and metabolise heterocyclic aromatic amines in vitro.

Authors:  Adriana Nowak; Zdzislawa Libudzisz
Journal:  Eur J Nutr       Date:  2009-05-16       Impact factor: 5.614

6.  Detoxification of mycotoxins by probiotic preparation for broiler chickens.

Authors:  J Biernasiak; M Piotrowska; Z Libudzisz
Journal:  Mycotoxin Res       Date:  2006-12       Impact factor: 3.833

7.  Isolation and characterization of human intestinal bacteria capable of transforming the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.

Authors:  Lynn Vanhaecke; Filip Vercruysse; Nico Boon; Willy Verstraete; Ilse Cleenwerck; Marjan De Wachter; Paul De Vos; Tom van de Wiele
Journal:  Appl Environ Microbiol       Date:  2008-01-11       Impact factor: 4.792

8.  Health-Promoting Properties of Lactobacillus helveticus.

Authors:  Valentina Taverniti; Simone Guglielmetti
Journal:  Front Microbiol       Date:  2012-11-19       Impact factor: 5.640

9.  The Ability of Probiotic Lactobacillus Strains in Removal of Benzo[a]pyrene: a Response Surface Methodology Study.

Authors:  Mojtaba Yousefi; Nasim Khorshidian; Hedayat Hosseini
Journal:  Probiotics Antimicrob Proteins       Date:  2021-06-15       Impact factor: 5.265

10.  Harnessing microbiome and probiotic research in sub-Saharan Africa: recommendations from an African workshop.

Authors:  Gregor Reid; Nicholas Nduti; Wilbert Sybesma; Remco Kort; Tobias R Kollmann; Rod Adam; Hamadi Boga; Eric M Brown; Alexandra Einerhand; Hani El-Nezami; Gregory B Gloor; Irene I Kavere; Johanna Lindahl; Amee Manges; Wondu Mamo; Rocio Martin; Amy McMillan; Jael Obiero; Pamela A Ochieng'; Arnold Onyango; Stephen Rulisa; Eeva Salminen; Seppo Salminen; Antony Sije; Jonathan R Swann; William van Treuren; Daniel Waweru; Steve J Kemp
Journal:  Microbiome       Date:  2014-04-16       Impact factor: 14.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.